Inebilizumab (FUT8-KO)

Product Overview

• Article Name: Inebilizumab (FUT8-KO)
• Biozol Catalog Number: MCE-HY-P99113A
• Supplier Catalog Number: HY-P99113A
• Alternative Catalog Number: MCE-HY-P99113A-1MG,MCE-HY-P99113A-25MG,MCE-HY-P99113A-10MG,MCE-HY-P99113A-5MG
• Manufacturer: MedchemExpress
• Category: Antikörper

Product Description

Inebilizumab (FUT8-KO) is an anti-CD19 monoclonal antibody expressed by CHO cells with the fucosyltransferase 8 gene (FUT8) knocked out. Fucose deficiency enhances the antibody-dependent cellular cytotoxicity (ADCC) effect of the antibody.Inebilizumab (FUT8-KO) exhibits enhanced ADCC against B cells and can be used for research on multiple sclerosis and neuromyelitis optica[1][2].

Product Properties

• Molecular Weight: (146.3 kDa)
• Purity: 97
• Target: CD19

Application Notes

• Application Notes: MCE Product type: Inhibitory Antibodies